AstraZeneca PLC (JOBS), Bristol-Myers Squibb Company (JOBS) Diabetes Drug Onglyza Wins U.S. OK
WASHINGTON, July 31 (Reuters) - AstraZeneca PLC (AZN.L) and Bristol-Myers Squibb Co (BMY.N) won U.S. approval on Friday to sell a new diabetes drug called Onglyza.